1. Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort
- Author
-
Yang Zhao, Sheng Guan, Yang Wang, Junlin Lu, Yuanli Zhao, Jianmin Liu, Hongqi Zhang, Xinjian Yang, Tianxiao Li, Huaizhang Shi, Jieqing Wan, Donglei Song, Aisha Maimaitili, Yunyan Wang, Wenfeng Feng, and Guohua Mao
- Subjects
Neurology. Diseases of the nervous system ,RC346-429 - Abstract
Background Unruptured intracranial aneurysm treatment aims to reduce the risk of aneurysm rupture and bleeding, relieves symptoms and improve the quality of life for patients. This study aimed to assess the safety and efficacy of Pipeline Embolization Device (PED, Covidien/Medtronic, Irvine, CA) treatment for intracranial aneurysms presenting with mass effect in real-world settings.Methods We selected patients from the PED in China Post-Market Multi-Center Registry Study with mass effect presentation. The study endpoints included postoperative mass effect deterioration and mass effect relief at follow-up (3–36 months). We conducted multivariate analysis to identify factors associated with mass effect relief. Subgroup analyses by aneurysm location, size and form were also performed.Results This study included 218 patients with a mean age of 54.3±11.8 years and a female predominance of 74.0% (162/218). The postoperative mass effect deterioration rate was 9.6% (21/218). During a median follow-up period of 8.4 months, the mass effect relief rate was 71.6% (156/218). Notably, immediate aneurysm occlusion following treatment was significantly associated with mass effect relief (OR 0.392, 95% CI, 0.170 to 0.907, p=0.029). Subgroup analysis demonstrated that adjunctive coiling contributed to mass effect relief in cavernous aneurysms, while dense embolism impeded symptom relief in aneurysms
- Full Text
- View/download PDF